Kathleen Bethin
Pediatric Endocrinology · Buffalo, NYNPI 1841305349
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (50.5%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. 15 manufacturers reported payments, led by Pfizer at 40.8% of the total. 2025 is the largest year on record at $6,020, 2.3 times the $2,574 reported in 2019.
Across 52 payments — averaging $269.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$6K
- Biomarin Pharmaceutical Inc.$3K
- Mannkind Corporation$2K
- Novo Nordisk AS$1K
- Eli Lilly$1K
- Tandem Diabetes Care, Inc.$361
- plus $958 from 9 others
Across 970 payments — averaging $808.87 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Boehringer Ingelheim$321K
- Novo Nordisk AS$154K
- Eli Lilly$148K
- Mannkind Corporation$64K
- Boehringer Ingelheim Pharma GmbH & Co.kg$52K
- AbbVie$25K
- plus $19K from 2 others
What the payments were for
- Speaking & faculty fees$7,07551%
- Travel & lodging$4,00229%
- Food & beverage$2,81520%
- Education$891%
- Other$200%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 8 | $5,716 |
| Biomarin Pharmaceutical Inc. | 5 | $2,579 |
| Mannkind Corporation | 8 | $1,941 |
| Novo Nordisk AS | 4 | $1,236 |
| Eli Lilly | 7 | $1,209 |
| Tandem Diabetes Care, Inc. | 3 | $361 |
| Medtronic | 2 | $258 |
| Sanofi-aventis U.S. LLC | 2 | $253 |
| Sequel Med Tech, LLC | 1 | $137 |
| Insulet Corporation | 2 | $125 |
| AbbVie | 4 | $58 |
| Lilly USA, LLC | 3 | $55 |
| Ultragenyx Pharmaceutical Inc. | 1 | $30 |
| AstraZeneca | 1 | $23 |
| Abbott | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NGENLA$3,726
- GENOTROPIN$1,917
- AFREZZA$1,709
- HUMALOG$1,173
- t:slim X2 Insulin Pump with Control-IQ$361
- VOXZOGO 1.2mg$259
- MINIMED 780G$258
- TWIIST$137
- TZIELD$108
- Omnipod$105
How this compares
$14,001 in reported general payments places this provider in the 85th percentile of 138 pediatric endocrinology providers in New York.
Other pediatric endocrinology in Buffalo
- Lucy MastrandreaBuffalo$2K
- Paul SaengerMineola$180K
- Alicia RomanoSleepy Hollow$157K
- Svetlana TenStaten Island$101K
- Robert RapaportNew York$98K
- Moris AnguloMineola$73K
- Jill BrodskyPoughkeepsie$45K
- Jorge Mejia-CorlettoNorth Babylon$44K
- Angela VerardoBronx$38K
- Christopher RomeroNew York$35K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.